174 related articles for article (PubMed ID: 10777211)
1. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
Vial E; Castellazzi M
Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
[TBL] [Abstract][Full Text] [Related]
2. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
Vial E; Perez S; Castellazzi M
Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
[TBL] [Abstract][Full Text] [Related]
4. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Cohen SB; Waha A; Gelman IH; Vogt PK
Oncogene; 2001 Jan; 20(2):141-6. PubMed ID: 11313943
[TBL] [Abstract][Full Text] [Related]
5. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
6. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
Perez S; Vial E; van Dam H; Castellazzi M
Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
[TBL] [Abstract][Full Text] [Related]
8. Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
Kato Y; Tsukuda M; Nagashima Y; Koshika S; Sakai N; Yao M; Kubota Y; Aoki I; Colledge WH; Foidart JM; Hata R; Thompson EW
Int J Oncol; 2005 Sep; 27(3):759-68. PubMed ID: 16077926
[TBL] [Abstract][Full Text] [Related]
9. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.
Castellazzi M; Dangy JP; Mechta F; Hirai S; Yaniv M; Samarut J; Lassailly A; Brun G
Oncogene; 1990 Oct; 5(10):1541-7. PubMed ID: 2123532
[TBL] [Abstract][Full Text] [Related]
11. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
12. A quail long-term cell culture transformed by a chimeric jun oncogene.
Hartl M; Vogt PK; Bister K
Virology; 1995 Feb; 207(1):321-6. PubMed ID: 7871748
[TBL] [Abstract][Full Text] [Related]
13. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
14. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
Mateos S; Amarir S; Laugier D; Marx M; Calothy G
Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-dependent nuclear location of the matricellular protein SPARC: association with the nuclear matrix.
Gooden MD; Vernon RB; Bassuk JA; Sage EH
J Cell Biochem; 1999 Aug; 74(2):152-67. PubMed ID: 10404386
[TBL] [Abstract][Full Text] [Related]
17. Involvement of SPARC in in vitro differentiation of skeletal myoblasts.
Cho WJ; Kim EJ; Lee SJ; Kim HD; Shin HJ; Lim WK
Biochem Biophys Res Commun; 2000 May; 271(3):630-4. PubMed ID: 10814513
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sarcoma cell lines from v-jun transgenic mice.
Marshall GM; Vanhamme L
Cancer Res; 1993 Feb; 53(3):622-6. PubMed ID: 8425197
[TBL] [Abstract][Full Text] [Related]
19. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
Weaver MS; Sage EH; Yan Q
J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
